Showing 21 - 30 of 75
Health economists have hypothesized for some time that physicians produce medical care in an inefficient manner. Further, whether solo or group practice physicians are relatively more inefficient has been a question of particular interest. Theoretical considerations suggest that solo and group...
Persistent link: https://www.econbiz.de/10005792852
Persistent link: https://www.econbiz.de/10005820576
We reviewed the literature on the efficacy and effectiveness of beta-blocker therapy and examined the economic consequences of under-utilisation. Despite the literature documenting the value of beta-blockers, the therapy is not prescribed at the appropriate rates. Approximately half of acute...
Persistent link: https://www.econbiz.de/10005243162
We explore the relative impact of informative versus the credence effects of direct-to-consumer advertising in the market for prescription drugs. In particular, we examine how advertising for statin medications affects the delay between diagnosis and pharmacological treatment for patients with...
Persistent link: https://www.econbiz.de/10010540646
Economists have long been interested in evaluating the role that time preferences play in a wide range of economic decisions. In the health care arena, time preferences may be an especially important determinant of many decisions—particularly the use of preventative health care. One potential...
Persistent link: https://www.econbiz.de/10008568022
This paper expands the standard model of utility maximization to endogenize the ubiquitous phenomenon of adaptation. We assume that total utility is an aggregate function of the utility associated with different domains of life, with relative weights that are optimized according to the effort...
Persistent link: https://www.econbiz.de/10008863841
"We examine how direct to consumer advertising affects the delay between diagnosis and pharmacological treatment for patients suffering from a common chronic disease. The primary data for this study consist of patients diagnosed with osteoarthritis ("N" = 18,235) taken from a geographically...
Persistent link: https://www.econbiz.de/10008473310
Illustrate the value of a strategy used for measuring the costs and resources used in the implementation process over and above the costs of the intervention itself in the context of a two-arm randomized controlled trial.
Persistent link: https://www.econbiz.de/10010753636
Persistent link: https://www.econbiz.de/10001502192
Persistent link: https://www.econbiz.de/10001182496